Jazz Pharmaceuticals (JAZZ) Interest & Investment Income (2010 - 2026)

Jazz Pharmaceuticals' Interest & Investment Income history runs 3 years deep, the most recent figure standing at $71000.0 for Q1 2012.

• In Q1 2012, Interest & Investment Income changed N/A year-over-year to $71000.0; the TTM figure through Mar 2012 stood at $146000.0 (changed N/A YoY), while the FY2011 annual figure was $75000.0, up 1775.0% from the prior year.
• Interest & Investment Income for Q1 2012 stood at $71000.0, up from $69000.0 in the prior quarter.
• The five-year high for Interest & Investment Income was $71000.0 in Q1 2012, with the low at -$3000.0 in Q3 2010.
• The 3-year median for Interest & Investment Income is $4000.0 (2010), against an average of $21142.9.
• Peak annual rise in Interest & Investment Income reached 6800.0% in 2011, while the deepest fall reached 50.0% in 2011.
• Jazz Pharmaceuticals' Interest & Investment Income stood at $1000.0 in 2010, then surged by 6800.0% to $69000.0 in 2011, then gained by 2.9% to $71000.0 in 2012.
• Business Quant data shows JAZZ's Interest & Investment Income at $71000.0 in Q1 2012, $69000.0 in Q4 2011, and $4000.0 in Q3 2011.